Breaking Down Ninestar Corporation Financial Health: Key Insights for Investors

CN | Technology | Semiconductors | SHZ

Ninestar Corporation (002180.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Ninestar Corporation's recent results demand a hard look: Q3 2025 revenue plunged to CNY 2.18 billion (a 67% year‑over‑year drop) while total operating revenue for the first three quarters fell 25.21% to CNY 14.50 billion, and Q3 reported a net loss attributable to shareholders of CNY 44 million (down 141.29% year‑on‑year) against a first‑half net loss of about CNY 311.77 million; profitability metrics show a Q3 net margin of -6.19% and H1 ROE slid to -3.12% from 9.89% last year, even as balance‑sheet figures reveal total assets of CNY 35.57 billion, total liabilities of CNY 25.69 billion, a debt‑to‑equity ratio of 0.43, but cash and short‑term investments have fallen 40.51% to CNY 4.06 billion and operating cash flow weakened (Q3 net cash from operations CNY 716 million, down 43%); valuation and market signals include EV/EBITDA of 13.17, EV/FCF of 25.40, P/S of 1.42, P/B of 3.14 and a market cap of CNY 26.21 billion (as of Dec 12, 2025), while key risks (U.S. Entity List restrictions, IP disputes, OEM competition, paperless trends) and growth levers (Lexmark divestiture, Telai cooperation on chips, MSCI ESG A rating, increased R&D and share repurchases) set the stage-read on to dissect what these hard numbers mean for investors and the trade‑offs between risk, liquidity and valuation.

Ninestar Corporation (002180.SZ) - Revenue Analysis

Key topline and profitability shifts for Ninestar Corporation (002180.SZ) through Q3 2025 highlight a pronounced revenue contraction and a swing to net losses.

  • Q3 2025 revenue: CNY 2.18 billion (down 67.00% year-over-year).
  • Total operating revenue, first three quarters 2025: CNY 14.50 billion (down 25.21% YOY).
  • Total operating revenue, first half 2025: CNY 12.33 billion (down 3.65% YOY).
  • Q3 2025 net profit attributable to shareholders: loss of CNY 44.00 million (decrease of 141.29% YOY).
  • Net profit attributable to shareholders, first half 2025: loss of ~CNY 311.77 million (decline of 132.02% from prior-year profit of CNY 973.64 million).
  • Net profit after deducting non-recurring items, first half 2025: loss of ~CNY 165.32 million (down 126.51% from prior-year profit of CNY 623.52 million).
Metric Q3 2025 H1 2025 First 3 Quarters 2025 YOY Change
Revenue CNY 2.18 billion CNY 12.33 billion CNY 14.50 billion -67.00% (Q3) / -25.21% (9M)
Net profit attributable to shareholders Loss CNY 44.00 million Loss CNY 311.77 million - -141.29% (Q3) / -132.02% (H1)
Net profit excluding non-recurring items - Loss CNY 165.32 million - -126.51% (H1)

Drivers, implications and focus areas for investors:

  • Revenue slump: a sharp Q3 decline (67%) suggests either demand weakness, product mix shifts, pricing pressure, or channel disruptions.
  • Profitability deterioration: swing to aggregate losses in H1 and Q3 driven by lower revenue and/or margin compression; non-recurring adjustments materially affect comparable profits.
  • Cash and working capital sensitivity: sustained revenue declines can strain cash flow and inventory turns-monitor quarterly operating cash flow and receivables trends.
  • Management responses to track: cost controls, inventory reduction, product portfolio reshaping, and moves to stabilize sales channels.
  • Valuation and risk: earnings volatility increases downside risk; assess balance sheet resilience and any contingent liabilities.

Context and further company background available here: Ninestar Corporation: History, Ownership, Mission, How It Works & Makes Money

Ninestar Corporation (002180.SZ) - Profitability Metrics

Key profitability indicators for Ninestar Corporation show material deterioration through Q3 2025 and the first half of 2025.

  • Q3 2025 net profit margin: -6.19% (decline of 157.85% YoY)
  • H1 2025 net profit margin: negative (significant decline vs. H1 prior year)
  • Q3 2025 EPS: negative (substantial YoY decrease)
  • H1 2025 ROE: -3.12% (down from 9.89% last year; change reported as -13.01%)
  • H1 2025 ROA: 0.59% (decrease vs. prior year)
  • H1 2025 ROIC: 1.11% (declined from prior-year level)
Metric Q3 2025 H1 2025 YoY change / Notes
Net profit margin -6.19% Negative Q3 decline of 157.85% YoY; H1 significant deterioration vs. prior year
Earnings per share (EPS) Negative - Q3 EPS turned negative, large YoY decrease
Return on equity (ROE) - -3.12% Down from 9.89% last year (reported decline 13.01%)
Return on assets (ROA) - 0.59% Lower than prior-year level
Return on invested capital (ROIC) - 1.11% Declined from previous year
  • Profitability pressure is evident across margin and return metrics; negative net margin and EPS in Q3 2025 highlight near-term operational stress.
  • ROE swing from 9.89% to -3.12% in H1 2025 signals equity returns reversal and potential capital allocation concerns.
  • ROA and ROIC remaining low (0.59% and 1.11%) indicate modest asset and capital efficiency during H1 2025.

Further context and investor positioning can be found here: Exploring Ninestar Corporation Investor Profile: Who's Buying and Why?

Ninestar Corporation (002180.SZ) - Debt vs. Equity Structure

Ninestar Corporation's balance-sheet dynamics through June 2025 show modest deleveraging alongside weaker liquidity and operating cash generation.
  • Total assets: CNY 35.57 billion (down 4.10% YoY)
  • Total liabilities: CNY 25.69 billion (down 3.29% YoY)
  • Total equity: CNY 9.88 billion (largely unchanged YoY)
  • Debt-to-equity ratio: 0.43 (June 2025)
  • Cash & short-term investments: CNY 4.06 billion (down 40.51% YoY)
  • Net cash flow from operating activities (Q3 2025): CNY 716 million (down 43% YoY)
Metric Amount (CNY) YoY Change Notes
Total assets (Jun 2025) 35.57 billion -4.10% Reflects asset contraction vs. Jun 2024
Total liabilities (Jun 2025) 25.69 billion -3.29% Liabilities reduced modestly
Total equity (Jun 2025) 9.88 billion ~0.0% Stable shareholders' equity
Debt-to-equity ratio 0.43 - Moderate leverage (Total liabilities / Total equity)
Cash & short-term investments 4.06 billion -40.51% Significant decline in liquid reserves
Operating cash flow (Q3 2025) 716 million -43.0% Weakened cash generation vs. prior year
  • Leverage context: A 0.43 debt-to-equity implies that liabilities are less than half of equity, limiting financial risk from debt burdens but not eliminating refinancing or working capital pressures given lower cash balances.
  • Liquidity risk: Cash decline of 40.5% to CNY 4.06 billion raises sensitivity to short-term obligations despite overall liabilities decreasing.
  • Cash conversion: A 43% drop in operating cash flow (Q3 2025) signals potential margin or working-capital stress that could force reliance on credit if trends persist.
  • Balance-sheet stability: Stable equity (CNY 9.88 billion) provides a buffer, but asset contraction (-4.1%) should be monitored for impacts on revenue capacity and collateral values.
Mission Statement, Vision, & Core Values (2026) of Ninestar Corporation.

Ninestar Corporation (002180.SZ) - Liquidity and Solvency

Ninestar's mid-2025 balance-sheet and cash-flow metrics show mixed liquidity strength but constrained solvency coverage from operating earnings.
  • Current ratio (June 2025): 2.64 - strong short-term asset coverage of short-term liabilities.
  • Quick ratio (June 2025): 1.35 - adequate immediate liquidity excluding inventories.
  • Interest coverage ratio (latest reported): 1.57 - limited ability to cover interest from operating income, signaling potential stress if earnings weaken further.
Metric Value YoY Change / Note
Current Ratio (Jun 2025) 2.64 -
Quick Ratio (Jun 2025) 1.35 -
Interest Coverage Ratio 1.57 Indicates limited coverage
Net Cash Flow from Operating Activities (Q3 2025) CNY 716 million Down 43% YoY
Cash & Short-term Investments (Jun 2025) CNY 4.06 billion Down 40.51% YoY
Total Liabilities (Jun 2025) CNY 25.69 billion Down 3.29% YoY
  • Large decrease in cash and short-term investments (-40.51% YoY) reduces buffer for operational shocks despite a healthy current ratio.
  • Significant YoY fall in operating cash flow (-43%) intensifies reliance on balance-sheet liquidity or external financing.
  • Moderate reduction in total liabilities (-3.29% YoY) slightly improves leverage but does not offset weaker cash generation and low interest coverage.
  • Interest coverage near 1.6 highlights vulnerability if interest rates rise or margins compress; refinancing risk should be monitored.
For broader context on company background and business model, see: Ninestar Corporation: History, Ownership, Mission, How It Works & Makes Money

Ninestar Corporation (002180.SZ) - Valuation Analysis

The following metrics provide a snapshot of how the market is valuing Ninestar Corporation across earnings, cash flow, revenue and net assets, plus recent market capitalization and quarterly EPS performance.

Metric Value Comment
EV / EBITDA 13.17 Moderate valuation relative to operating earnings
EV / Free Cash Flow 25.40 Higher multiple on cash generation
Price / Sales (P/S) 1.42 Market values each CNY 1 of sales at CNY 1.42
Price / Book (P/B) 3.14 Shares trade above net asset value
EPS (Q3 2025) Negative Company reported a loss in the quarter
Market Capitalization (12 Dec 2025) CNY 26.21 billion Total equity market value on that date
  • EV/EBITDA = 13.17 suggests the market expects stable earnings but is not pricing a deep growth premium.
  • EV/FCF = 25.40 indicates cash flow is valued more richly than EBITDA, implying investors may expect future cash conversion or conservatively low current FCF.
  • P/S at 1.42 is modest - revenue is being valued above replacement but not at stretched multiples typical of high-growth names.
  • P/B of 3.14 shows investors are paying a significant premium over book value, reflecting intangible assets, brand, or expected returns above ROE breakeven.
  • Negative EPS in Q3 2025 is a cautionary signal; reconcile periodic profitability with longer-term cash flow and balance-sheet strength.

For context on strategy and corporate positioning that may drive these valuation metrics see: Mission Statement, Vision, & Core Values (2026) of Ninestar Corporation.

Ninestar Corporation (002180.SZ) - Risk Factors

The following risk factors materially affect Ninestar Corporation's (002180.SZ) financial health, operations and investor outlook. Each item includes practical implications and estimated financial metrics where relevant.

  • U.S. Entity List designation (2023): Being added to the U.S. Entity List restricts access to certain U.S. origin technologies, components and software, complicating supply chains and product development timelines.
  • Intellectual property (IP) litigation exposure: Ongoing cartridge- and printer-related patent disputes in multiple jurisdictions increase legal costs, potential damages and injunction risk.
  • Competitive pressure: Incumbent OEMs (HP, Canon, Epson) and global aftermarket suppliers tighten pricing and margin headroom.
  • Demand secular shift: Long-term digitalization and reduction in print volumes threaten recurring consumables revenue.
  • Post-acquisition leverage: Debt levels rose after the Lexmark-related acquisitions and business integrations, increasing interest burden and leverage sensitivity.
  • Currency & geopolitical risk: FX volatility and cross-border tensions may compress margins and disrupt international sales.
Risk Primary Financial Impact Estimated/Observed Metric
Entity List restrictions Supply chain delays, potential loss of U.S. customer contracts, higher sourcing costs Export control listing since 2023; vendor requalification cost spike estimated +5-10% on affected SKUs
IP litigation Legal expenses, settlement or damages, injunction risk reducing sales Ongoing multi-jurisdiction cases; legal provisions / contingencies can range from RMB 50-300 million per major suit
Competition Price erosion, lower ASPs, margin compression Gross margin pressure: potential downshift of 200-700 bps in high-competition segments
Declining print demand Lower consumables volumes, reduced LTV per customer Annual global mono laser page decline trend mid-single digits; addressable market contraction ~2-5% p.a.
Debt from Lexmark-related activity Higher interest expense, elevated leverage ratios Reported long-term borrowings rose materially post-acquisition; debt-to-equity increase estimated +20-50% versus pre-acquisition
FX & geopolitics Translation losses, hedging costs, market access limitations FX sensitivity: 1% RMB movement can affect net profit by several percentage points in export-heavy quarters

Operationally and financially, these risks interact. For example, Entity List constraints may necessitate alternate sourcing that raises COGS while simultaneously slowing product launches, which compounds margin and revenue impacts. IP outcomes (injunctions or damages) could directly remove product lines or require licensing fees, impacting net income and cash flow.

  • Near-term cash-flow & leverage considerations:
    • Interest coverage: Increased debt can reduce EBITDA/interest coverage ratios; a hypothetical 30% rise in net debt could lower coverage from comfortable levels to moderately constrained levels in stress scenarios.
    • Working capital: Supply chain disruption often increases inventory days and working capital needs; a 10-20% jump in inventory tied to re-sourcing is plausible.
    • Contingent liabilities: IP and regulatory disputes create off-balance-sheet risk that may require provisions if outcomes turn adverse.

Key metrics investors should monitor quarter-to-quarter:

  • Revenue by region and channel (to spot loss of U.S. business or OEM contracts)
  • Gross margin and gross margin drivers (COGS increases from re-sourcing or tariffs)
  • Net debt / EBITDA and interest coverage ratio
  • Legal provisions, contingent liabilities and outcomes of major IP cases
  • Capital expenditure and R&D spend on alternative tech to mitigate Entity List limits

For more on the company's broader context, refer to: Ninestar Corporation: History, Ownership, Mission, How It Works & Makes Money

Ninestar Corporation (002180.SZ) - Growth Opportunities

Ninestar Corporation is positioning for multi-dimensional growth driven by strategic partnerships, portfolio realignment, sustainability credentials, increased commercial investment, and shareholder-return actions. Key developments and quantified indicators include:

  • Strategic cooperation with Telai Electric New Energy to expand market reach and co-develop product innovations focused on MCU, DSP and related chips, supporting product diversification into semiconductor-enabled devices.
  • Completion of required legal procedures for the major asset sale of Lexmark International II, LLC to Xerox Corporation - a transaction that can enable strategic realignment of Ninestar's capital allocation and go-to-market focus.
  • MSCI upgraded Ninestar's ESG rating to A in 2024, strengthening its sustainability profile and potential appeal to ESG-focused investors and customers.
  • Planned increase in investment across R&D, brand promotion, and offline service channel construction - reflected in a 21.45% rise in Pantum-related expenses, indicating a push to scale the Pantum brand and after-sales footprint.
  • Active share repurchase program: 7,350,100 shares repurchased (0.52% of total share capital) for approximately RMB 159.85 million; board authorized further repurchases of RMB 200-400 million at a cap price of RMB 40.42 per share.
Metric Value Notes
Shares repurchased (completed) 7,350,100 Represents 0.52% of total share capital
Repurchase cash deployed RMB 159.85 million Aggregated payment for completed repurchases
Planned repurchase fund (announced) RMB 200 million - RMB 400 million Price per share cap: ≤ RMB 40.42
Estimated total shares outstanding (approx.) ~1,413,096,154 shares Derived from repurchased shares / 0.52%
Pantum business expense increase +21.45% Higher R&D, marketing and offline service channel costs
MSCI ESG Rating (2024) A Elevated in 2024
Lexmark II, LLC sale status Legal procedures completed Sale to Xerox Corporation - enables strategic capital/portfolio adjustments
Target collaboration areas with Telai MCU, DSP, other chips Product innovation and market expansion
  • Cash deployment and buyback flexibility: the announced RMB 200-400 million repurchase authorization, together with the ~RMB 159.85 million already spent, indicates management's willingness to return capital while supporting the share price - at a maximum price of RMB 40.42 per share.
  • R&D and brand investment signal a near-term margin trade-off (higher operating expenses) aimed at mid-to-long-term revenue and market-share gains, especially in the Pantum channel and new chip-enabled product lines.
  • Improved ESG rating is likely to enhance access to sustainability-focused capital and improve relationships with enterprise customers prioritizing supplier ESG performance.

For corporate mission and strategic context, see: Mission Statement, Vision, & Core Values (2026) of Ninestar Corporation.

DCF model

Ninestar Corporation (002180.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.